Publication of our CSR 2023 brochure

August 2023

In 2022, Provepharm reached an important milestone in its CSR strategy. In this "2023 CSR Impact", the essential elements of our approach have been grouped together.

Provepharm aims to build, day after day, an economy with a reduced environmental impact and a greater social impact, an economy that serves people without harming the environment.

Michel Feraud Founder & CEO of Provepharm

You are about to leave the Provepharm Corporate website. If you continue you will reach the website of our US subsidiary which the information is not necessarily applicable to France.